$SHOT
Safety Shot, Inc. Stock $shot

$shot Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223010480 Filed on April 03, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$1.122M	$905.6K	$6.197M
YoY Change	55.44%	-41.36%	115.44%
Cost Of Revenue	$875.0K	$915.0K	$5.170M
YoY Change	44.77%	-24.85%	120.88%
Gross Profit	$246.6K	-$9.400K	$1.026M
YoY Change	110.43%	-102.88%	91.67%
Gross Profit Margin	21.99%	-1.04%	16.56%
Selling, General & Admin	$1.382M	$6.210M	$11.62M
YoY Change	-25.32%	-7.19%	-27.58%
% of Gross Profit	560.29%		1131.75%
Research & Development	$33.15K	$672.6K	$1.637M
YoY Change	-67.83%	316.05%	51.67%
% of Gross Profit	13.44%		159.51%
Depreciation & Amortization	$23.19K	$448.2K	$95.81K
YoY Change	-8.64%	199.93%	-49.02%
% of Gross Profit	9.4%		9.33%
Operating Expenses	$1.497M	$6.906M	$14.97M
YoY Change	-49.76%	-59.31%	-45.19%
Operating Profit	-$1.250M	-$6.915M	-$13.94M
YoY Change	-56.32%	-58.45%	-47.93%
Interest Expense	-$116.4K	-$161.7K	-$1.285M
YoY Change	461.85%	331.0%	-25.69%
% of Operating Profit
Other Income/Expense, Net	-$58.28K	-$3.270K	-$1.283M
YoY Change	56.08%	-109.18%	-4306.9%
Pretax Income	-$1.308M	-$8.530M	-$15.22M
YoY Change	-55.2%	-49.66%	-45.83%
Income Tax
% Of Pretax Income
Net Earnings	-$1.308M	-$8.530M	-$15.22M
YoY Change	-55.2%	-49.66%	-45.83%
Net Earnings / Revenue	-116.63%	-941.91%	-245.66%
Basic Earnings Per Share	-$0.05		-$0.69
Diluted Earnings Per Share	-$0.05	-$0.39	-$0.69
COMMON SHARES
Basic Shares Outstanding	26.65M shares	21.89M shares	22.11M shares
Diluted Shares Outstanding	25.55M shares		22.11M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.968M	$4.848M	$4.848M
YoY Change	-23.03%	-66.93%	-66.93%
Cash & Equivalents	$3.737M	$1.931M
Short-Term Investments	$3.231M	$2.917M	$2.917M
Other Short-Term Assets	$909.5K	$814.1K	$814.1K
YoY Change	-2.56%	31.88%	31.88%
Inventory	$265.9K	$441.4K	$441.4K
Prepaid Expenses	$909.5K	$814.1K
Receivables	$860.7K	$647.5K	$647.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.005M	$6.751M	$6.751M
YoY Change	-16.69%	-58.53%	-58.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$82.94K	$61.83K	$705.8K
YoY Change	-89.92%	-43.31%	-22.13%
Goodwill	$941.9K	$941.9K
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.902M	$1.939M	$1.939M
YoY Change	-23.49%	-25.06%	-25.06%
TOTAL ASSETS
Total Short-Term Assets	$9.005M	$6.751M	$6.751M
Total Long-Term Assets	$1.902M	$1.939M	$1.939M
Total Assets	$10.91M	$8.691M	$8.691M
YoY Change	-17.97%	-53.94%	-53.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.817M	$1.927M	$1.927M
YoY Change	272.18%	55.05%	55.05%
Accrued Expenses	$585.0K	$366.6K	$530.8K
YoY Change	20.95%	128.41%	90.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.049M	$2.048M	$2.048M
YoY Change	4171.4%	4206.06%	4206.06%
Total Short-Term Liabilities	$4.637M	$4.506M	$4.506M
YoY Change	354.68%	187.14%	187.14%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$461.1K	$519.7K	$519.7K
YoY Change	-25.73%	-25.33%	-25.33%
Total Long-Term Liabilities	$461.1K	$519.7K	$519.7K
YoY Change	-25.73%	-25.33%	-25.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.637M	$4.506M	$4.506M
Total Long-Term Liabilities	$461.1K	$519.7K	$519.7K
Total Liabilities	$5.099M	$5.025M	$5.025M
YoY Change	210.74%	121.86%	121.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$51.91M	-$50.60M
YoY Change		43.03%
Common Stock	$26.66K	$22.34K
YoY Change		-7.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.808M	$3.666M	$3.666M
YoY Change
Total Liabilities & Shareholders Equity	$10.91M	$8.691M	$8.691M
YoY Change	-17.97%	-53.94%	-53.94%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.308M	-$8.530M	-$15.22M
YoY Change	-55.2%	-49.66%	-45.83%
Depreciation, Depletion And Amortization	$23.19K	$448.2K	$95.81K
YoY Change	-8.64%	199.93%	-49.02%
Cash From Operating Activities	-$1.469M	-$1.646M	-$6.396M
YoY Change	-45.83%	-35.47%	-15.48%
INVESTING ACTIVITIES
Capital Expenditures	$26.08K	-$20.40K	$14.99K
YoY Change	-707.9%	397.56%	-106.29%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$2.457M
YoY Change	-100.0%	-100.0%	-80.97%
Cash From Investing Activities	-$26.08K	$20.40K	-$2.472M
YoY Change	-97.29%	-100.16%	-81.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.302M	-9.080K	-$955.6K
YoY Change	-270.64%	-112.82%	-103.39%
NET CHANGE
Cash From Operating Activities	-$1.469M	-1.646M	-$6.396M
Cash From Investing Activities	-$26.08K	20.40K	-$2.472M
Cash From Financing Activities	$3.302M	-9.080K	-$955.6K
Net Change In Cash	$1.806M	-1.634M	-$9.823M
YoY Change	-132.2%	-89.18%	-231.11%
FREE CASH FLOW
Cash From Operating Activities	-$1.469M	-$1.646M	-$6.396M
Capital Expenditures	$26.08K	-$20.40K	$14.99K
Free Cash Flow	-$1.496M	-$1.625M	-$6.411M
YoY Change	-44.79%	-36.17%	-12.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001760903
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	JUPW	Intellectual Property Non Current IntellectualPropertyNonCurrent		usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	JUPW	Treasury Shares Cancelled TreasurySharesCancelled		usd
CY2022	JUPW	Management Common Shares Cancelled ManagementCommonSharesCancelled		usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2021	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
CY2022	JUPW	Increase Decrease In Legal Fees IncreaseDecreaseInLegalFees		usd
CY2022	JUPW	Payment Paid For Intellectual Property PaymentPaidForIntellectualProperty		usd
CY2022	JUPW	Cash Loaned To Affiliate CashLoanedToAffiliate		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2022	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent		usd
CY2021	JUPW	Purchase Of Treasury Stock PurchaseOfTreasuryStock		usd
CY2021	JUPW	Payment Of Loan To Affiliate PaymentOfLoanToAffiliate		usd
CY2021	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt		usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	JUPW	Cancellation Of Shares Issued To Management CancellationOfSharesIssuedToManagement		usd
CY2021	JUPW	Treasury Shares Cancelled One TreasurySharesCancelledOne		usd
CY2022	JUPW	Cashless Exercise Of Options CashlessExerciseOfOptions		usd
CY2022	JUPW	Initial Rou Asset And Lease Liability InitialRouAssetAndLeaseLiability		usd
CY2022	JUPW	Fair Value Of Shares Issued For Intellectual Property FairValueOfSharesIssuedForIntellectualProperty		usd
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39569
CY2022	dei	Entity Registrant Name EntityRegistrantName	Jupiter Wellness, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-2455880
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1061 E. Indiantown Rd.
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 110
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Jupiter
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33477
CY2022	dei	City Area Code CityAreaCode	(561)
CY2022	dei	Local Phone Number LocalPhoneNumber	244-7100
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	12152798	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26654675	shares
CY2022	dei	Auditor Firm AuditorFirmId	2738
CY2022	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2022	dei	Auditor Location AuditorLocation	Houston, TX
CY2022Q4	us-gaap	Cash Cash	1931068	usd
CY2021Q4	us-gaap	Cash Cash	11754558	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	441404	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	304266	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	647530	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	695319	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	814114	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	617302	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	2917373	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	2908300	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6751489	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	16279745	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	643977	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	477000	usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	285000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	797311	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	291533	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	364417	usd
CY2021Q4	JUPW	Intellectual Property Non Current IntellectualPropertyNonCurrent	375000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	941937	usd
CY2021Q4	us-gaap	Goodwill Goodwill	941937	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	61827	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	109055	usd
CY2022Q4	us-gaap	Assets Assets	8690763	usd
CY2021Q4	us-gaap	Assets Assets	18867465	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1927188	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1242928	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	164170	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	118102	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	366619	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	160508	usd
CY2022Q4	JUPW	Loan Payable Current LoanPayableCurrent	47533	usd
CY2021Q4	JUPW	Loan Payable Current LoanPayableCurrent	47547	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4505510	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1569085	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	519659	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	695961	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5025169	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2265046	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22388888	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22388888	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24046001	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24046001	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	22339	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	24046	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53763929	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	51668019	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50597674	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35374646	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3665594	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16602419	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8690763	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18867465	usd
CY2022	us-gaap	Revenues Revenues	6196743	usd
CY2021	us-gaap	Revenues Revenues	2876273	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	5170386	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	2340788	usd
CY2022	us-gaap	Gross Profit GrossProfit	1026357	usd
CY2021	us-gaap	Gross Profit GrossProfit	535485	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12516279	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17306651	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1450000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	300000	usd
CY2022	JUPW	Impairment Of Secured Promissory Note ImpairmentOfSecuredPromissoryNote	1000000	usd
CY2021	JUPW	Impairment Of Secured Promissory Note ImpairmentOfSecuredPromissoryNote	10000000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	14966279	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	27606651	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	1718	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	7323	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	1286368	usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	1736106	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1544	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	699704	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1283106	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1029079	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15223028	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-28100245	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.69
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22106703	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16603788	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	4393541	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	28318314	usd
CY2021	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	525000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	560496	usd
CY2021	JUPW	Common Stock Issued For Services CommonStockIssuedForServices	4340983	usd
CY2021	JUPW	Contributed Capital ContributedCapital	70818	usd
CY2021	JUPW	Fair Value Of Stock Options Granted To Officers And Directors FairValueOfStockOptionsGrantedToOfficersAndDirectors	5046982	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1446530	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-28100245	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16602419	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16602419	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	862125	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2880045	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	277500	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1644184	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	142169	usd
CY2022	JUPW	Common Stock Issued For Services CommonStockIssuedForServices	192000	usd
CY2022	JUPW	Fair Value Of Stock Options Granted To Officers And Directors FairValueOfStockOptionsGrantedToOfficersAndDirectors	2048270	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15223028	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3665594	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3665594	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15223028	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-28100245	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3244564	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	9387965	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	937209	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	95805	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	187917	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1104477	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1604030	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	425000	usd
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	3702	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	34499	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7513	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	669200	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	1450000	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	300000	usd
CY2022	JUPW	Impairment Of Secured Promissory Note ImpairmentOfSecuredPromissoryNote	1000000	usd
CY2021	JUPW	Impairment Of Secured Promissory Note ImpairmentOfSecuredPromissoryNote	10000000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	196812	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	447721	usd
CY2022	JUPW	Increase Decrease In Right Of Entry Assets IncreaseDecreaseInRightOfEntryAssets	-153334	usd
CY2021	JUPW	Increase Decrease In Right Of Entry Assets IncreaseDecreaseInRightOfEntryAssets	-102252	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-47789	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	401398	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	137138	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	78342	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	684260	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	554093	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	152536	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	81471	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-130234	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-86481	usd
CY2021	JUPW	Increase Decrease In Legal Fees IncreaseDecreaseInLegalFees	25000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6395942	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7567645	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14991	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	88297	usd
CY2021	JUPW	Payment Paid For Intellectual Property PaymentPaidForIntellectualProperty	150000	usd
CY2021	JUPW	Cash Loaned To Affiliate CashLoanedToAffiliate	2908300	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1000000	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	10000000	usd
CY2022	JUPW	Payment To Research Agreement PaymentToResearchAgreement	1500000	usd
CY2022	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	43000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2471991	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13146597	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	28318314	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1880000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2967500	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3150000	usd
CY2021	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	70818	usd
CY2022	JUPW	Purchase Of Treasury Stock PurchaseOfTreasuryStock	2880045	usd
CY2022	JUPW	Payment Of Loan To Affiliate PaymentOfLoanToAffiliate	9073	usd
CY2022	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	241272	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	187711	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-955557	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28206632	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9823490	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7492390	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11754558	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4262168	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1931068	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11754558	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	277500	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	560496	usd
CY2022	JUPW	Fair Value Of Warrants Issued And Beneficial Conversion Feature In Connection With Convertible Promissory Notes FairValueOfWarrantsIssuedAndBeneficialConversionFeatureInConnectionWithConvertiblePromissoryNotes	706977	usd
CY2021	JUPW	Fair Value Of Warrants Issued And Beneficial Conversion Feature In Connection With Convertible Promissory Notes FairValueOfWarrantsIssuedAndBeneficialConversionFeatureInConnectionWithConvertiblePromissoryNotes	1446530	usd
CY2022	JUPW	Cancellation Of Shares Issued To Management CancellationOfSharesIssuedToManagement	57	usd
CY2022	JUPW	Treasury Shares Cancelled One TreasurySharesCancelledOne	2880045	usd
CY2021	JUPW	Cashless Exercise Of Options CashlessExerciseOfOptions	222	usd
CY2021	JUPW	Initial Rou Asset And Lease Liability InitialRouAssetAndLeaseLiability	870406	usd
CY2021	JUPW	Fair Value Of Shares Issued For Intellectual Property FairValueOfSharesIssuedForIntellectualProperty	525000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50597674	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35374646	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6395942	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7567645	usd
CY2022Q4	us-gaap	Cash Cash	1931068	usd
CY2022Q4	JUPW	Working Capital WorkingCapital	2245979	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zp41ZLqv1kZ7" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zsDwAQTcPq67">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	152432	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	23623	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	123094	usd
CY2022Q4	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	5715	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15223028	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-28100245	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22106703	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16603788	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22106703	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16603788	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.69
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.69
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1450000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	300000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1637117	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1079362	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	7110329	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	7110329	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	647530	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	695319	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	814114	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	617302	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	441404	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	304266	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	152432	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	23623	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	123094	usd
CY2022Q4	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	5715	usd
CY2022Q4	us-gaap	Investments Investments	2908300	usd
CY2021Q4	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	100000000	usd
CY2021Q4	us-gaap	Investments In And Advances To Affiliates At Fair Value Period Increase Decrease InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease	138000000	usd
CY2022Q4	us-gaap	Investments In And Advances To Affiliates Balance Shares InvestmentsInAndAdvancesToAffiliatesBalanceShares	1437500	shares
CY2022	us-gaap	Partners Capital Account Units Sold In Private Placement PartnersCapitalAccountUnitsSoldInPrivatePlacement	288830	shares
CY2022Q4	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	9073	usd
CY2022Q4	JUPW	Intellectual Property IntellectualProperty	0	usd
CY2021Q4	JUPW	Intellectual Property IntellectualProperty	375000	usd
CY2022Q4	JUPW	Clinical Research Agreement ClinicalResearchAgreement	1500000	usd
CY2022Q4	JUPW	Amount Of Clinical Research Agreement AmountOfClinicalResearchAgreement	3000000	usd
CY2020Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	525000	usd
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	32856	usd
CY2021Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	525000	usd
CY2021Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	35496	usd
CY2021Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	186832	shares
CY2021Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	3.00
CY2021Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3150000	usd
CY2021Q2	us-gaap	Debt Instrument Convertible Terms Of Conversion Feature DebtInstrumentConvertibleTermsOfConversionFeature	The 2021 Notes were issued with an Original Issue Discount (“OID”) of five percent (5%), a term of six months, an annual interest rate of eight percent (8%) and convertible into shares of the Company’s common stock at a conversion price of $6.00 per share.
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	525000	shares
CY2021Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	1026300	usd
CY2021Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	203532	usd
CY2021Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	62033	usd
CY2022Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	1245279	usd
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	442650	shares
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	525000	usd
CY2021	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	525000	usd
CY2021	us-gaap	Notes Issued1 NotesIssued1	3150000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3150000	usd
CY2022	us-gaap	Notes Issued1 NotesIssued1	2000000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2000000	usd
CY2020Q3	us-gaap	Loss Contingency Name Of Plaintiff LossContingencyNameOfPlaintiff	Ms. Whitley
CY2020Q3	us-gaap	Loss Contingency Name Of Defendant LossContingencyNameOfDefendant	Magical Beasts
CY2020Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1000000	usd
CY2020Q4	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	336450	usd
CY2020Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	300000	usd
CY2020Q4	JUPW	Shares Issued For Legal Settlement SharesIssuedForLegalSettlement	8500	shares
CY2020Q4	JUPW	Loss Contingency Damages Sought Value Outstanding LossContingencyDamagesSoughtValueOutstanding	691500	usd
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	669200	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22388888	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22388888	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24046001	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24046001	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	28318314	usd
CY2022	JUPW	Capital Structure Description CapitalStructureDescription	the Company submitted a final compliance plan to Nasdaq consisting of the following corrective actions: (1) on July 20, 2022, the Company’s four executive officers (Messrs. John, Miller, and McKinnon and Dr. Wilson), all of whom are on the Company’s Board of Directors except for Mr. McKinnon, each cancelled 2,750 options issued to them in August 2021 pursuant to an Incentive Stock Option Forfeiture Agreement. The cancellation of the 11,000 options in total enabled the issuance of 11,000 shares to a non-executive employee that took place in 2021 to be reallocated to be accounted for as if it was originally issued under the 2020 Equity Incentive Plan. The Company’s Board of Directors passed a resolution on July 25, 2022, making the corresponding change to the Company’s books and records with regard to the 11,000 shares; and (2) on July 26, 2022, the same four executive officers, returned, and the Company cancelled, a total of 56,496 shares of common stock issued to them in 2021 outside of a shareholder approved equity compensation plan.
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	285000	usd
CY2022	JUPW	Common Stock Issued For Services CommonStockIssuedForServices	192000	usd
CY2022	JUPW	Stock Payable StockPayable	477000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1123333	shares
CY2020Q4	JUPW	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	8.30
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	13698125	shares
CY2021Q4	JUPW	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	3.24
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	15958126	shares
CY2022Q4	JUPW	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	3.19
CY2022Q4	JUPW	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	15958126	shares
CY2022Q4	JUPW	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice	3.19
CY2022	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	211000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8134280	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4584280	shares
CY2020Q1	JUPW	Closing Cash ClosingCash	250000	usd
CY2020Q1	us-gaap	Notes Payable Current NotesPayableCurrent	1000000	usd
CY2020Q4	JUPW	Note Payable Discount Price NotePayableDiscountPrice	950427	usd
CY2020Q1	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	250000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.00
CY2020Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	156612	usd
CY2020Q1	us-gaap	Officers Compensation OfficersCompensation	150000	usd
CY2020Q3	us-gaap	Business Combination Assets Arising From Contingencies Amount Recognized BusinessCombinationAssetsArisingFromContingenciesAmountRecognized	250000	usd
CY2020Q4	JUPW	Business Acquisiton Of Note Payable BusinessAcquisitonOfNotePayable	1000000	usd
CY2020Q4	JUPW	Business Acquisitionof Settlement Agreement BusinessAcquisitionofSettlementAgreement	336450	usd
CY2020Q4	JUPW	Business Acquisition Of Agreement Payment BusinessAcquisitionOfAgreementPayment	1000000	usd
CY2020Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	300000	usd
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8500	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	8500	usd
CY2020Q4	JUPW	Business Acquisiton Offset Amount BusinessAcquisitonOffsetAmount	308500	usd
CY2020Q4	JUPW	Business Acquisiton Of Note Payable BusinessAcquisitonOfNotePayable	1000000	usd
CY2021Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	334000	usd
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	150000	usd
CY2021Q1	us-gaap	Ownshare Lending Arrangement Dividends Not Reimbursed OwnshareLendingArrangementDividendsNotReimbursed	5541	usd
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	669200	usd
CY2021Q1	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	691500	usd
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	22300	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	180456	usd
CY2022Q4	JUPW	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	240662	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	201260	usd
CY2022Q4	JUPW	Lessee Operating Lease Liability Payments Due Year Seven LesseeOperatingLeaseLiabilityPaymentsDueYearSeven	247882	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	224330	usd
CY2022Q4	JUPW	Lessee Operating Lease Liability Payments Due Year Eight LesseeOperatingLeaseLiabilityPaymentsDueYearEight	255319	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	229312	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	233653	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	519659	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	60626	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	231790	usd
CY2020Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	5000000	usd
CY2020Q3	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	5000000	usd
CY2020Q3	JUPW	Claiming Damages ClaimingDamages	10	usd
CY2020Q3	us-gaap	Other Commitments Description OtherCommitmentsDescription	In doing so, Judge Liman suggested that a jury could find that the Koch Parties would be fully compensated if the parties simply unwound the domain transfer, or that the jury might quantify the website’s value by looking to the amounts that the Koch Parties had paid for other, similar websites: between $12.17 and $65.98

Files In Submission

Name	View Source	Status
0001493152-23-010480-index-headers.html	Edgar Link	pending
0001493152-23-010480-index.html	Edgar Link	pending
0001493152-23-010480.txt	Edgar Link	pending
0001493152-23-010480-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
jupw-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
jupw-20221231_cal.xml	Edgar Link	unprocessable
jupw-20221231_lab.xml	Edgar Link	unprocessable
jupw-20221231_def.xml	Edgar Link	unprocessable
jupw-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHOT
Safety Shot, Inc. Stock $shot

2023 Q1 Form 10-K Financial Statement

#000149315223010480 Filed on April 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHOT Safety Shot, Inc. Stock $shot

2023 Q1 Form 10-K Financial Statement

#000149315223010480 Filed on April 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHOT
Safety Shot, Inc. Stock $shot